John Libbey Eurotext

Magnesium Research

Magnesium and depression Volume 29, numéro 3, September 2016

  • [1] Rude R.K., Shils M.E. Magnesium. In: Shils M.E., Shike M., Ross A.C., Caballero B., Cousins R.J., eds. Modern nutrition in health and disease. Baltimore: Lippincott Williams & Wilkins; 2006. 10th ed223-247
  • [2] Food and Nutrition Board, Institute of Medicine. Magnesium. dietary reference intakes: calcium, phosphorus, magnesium, vitamin D and fluoride. Washington D.C: National Academy Press; 1997. 190-249
  • [3] Spencer H., Norris C., Williams D. Inhibitory effects of zinc on magnesium balance and magnesium absorption in man. J Am Coll Nutr. 1994;13:479-484.
  • [4] Shils M.E. Magnesium. In: O’Dell B.L., Sunde R.A., eds. Handbook of nutritionally essential minerals. New York: Marcel Dekker, Inc; 1997. 117-152
  • [5] Rude R.K. Magnesium. In: Coates P.M., Betz J.M., Blackman M.R., Cragg G.M., Levine M., Moss J., White J.D., eds. Encyclopedia of dietary supplements. New York, NY: Informa Healthcare; 2010. 2nd ed527-37
  • [6] Chaudhary D.P., Sharma R., Bansal D.D. Implications of magnesium deficiency in type 2 diabetes: a review. Biol Trace Elem Res. 2010;134:119-129.
  • [7] U.S. Food and Drug Administration. Proton pump inhibitor drugs (Ppis): drug safety communication – low magnesium levels can be associated with long-term use. 2011.
  • [8] Sarafidis P.A., Georgianos P.I., Lasaridis A.N. Diuretics in clinical practice. Part II: electrolyte and acid-base disorders complicating diuretic therapy. Expert Opin Drug Saf. 2010;9:259-273.
  • [9] Papadopol V., Tuchendria E., Palamaru I. Magnesium and some psychological features in two groups of pupils (magnesium and psychic features). Magnes Res. 2001;14:27-32.
  • [10] Derom M.L., Martinez-Gonzalez M.A., Sayon-Orea M.C., Bes-Rastrollo M., Beunza J.J., Sanchez-Villegas A. Magnesium intake is not related to depression risk in Spanish university graduates. J Nutr. 2012;142:1053-1059.
  • [11] Singewald N., Sinner C., Hetzenauer A., Sartori S.B., Murck H. Magnesium-deficient diet alters depression- and anxiety-related behavior in mice – influence of desipramine and extract. Neuropharmacology. 2004;47:1189-1197. Hypericum perforatum
  • [12] Henrotte J.G., Franck G., Santarromana M., Frances H., Mouton D., Motta R. Mice selected for low and high blood magnesium levels: a new model for stress studies. Physiol Behav. 1997;61:653-658.
  • [13] Jacka F.N., Overland S., Stewart R., Tell G.S., Bjelland I., Mykletun A. Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study. Aust N Z J Psychiatry. 2009;43:45-52.
  • [14] Tarleton E.K., Littenberg B. Magnesium intake and depression in adults. J Am Board Fam Med. 2015;28:249-256.
  • [15] Malon A., Brockmann C., Fijalkowska-Morawska J., Rob P., Maj-Zurawska M. Ionized magnesium in erythrocytes – the best magnesium parameter to observe hypo- or hypermagnesemia. Clin Chim Acta. 2004;349:67-73.
  • [16] Gibson R.S. Principles of nutritional assessment, 2nd ed. New York, NY: Oxford University Press; 2005.
  • [17] Ebel H., Gunther T. Magnesium metabolism: a review. J Clin Chem Clin Biochem. 1980;18:257-270.
  • [18] George M.S., Rosenstein D., Rubinow D.R., Kling M.A., Post R.M. CSF magnesium in affective disorder: lack of correlation with clinical course of treatment. Psychiatry Res. 1994;51:139-146.
  • [19] Banki C.M., Vojnik M., Papp Z., Balla K.Z., Arato M. Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol Psychiatry. 1985;20:163-171.
  • [20] Levine J., Stein D., Rapoport A., Kurtzman L. High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients. Neuropsychobiology. 1999;39:63-70.
  • [21] Sowa-Kucma M., Szewczyk B., Sadlik K. Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims. J Affect Disord. 2013;151:924-931.
  • [22] Frazer A., Ramsey T.A., Swann A. Plasma and erythrocyte electrolytes in affective disorders. J Affect Disord. 1983;5:103-113.
  • [23] Linder J., Brismar K., Beck-Friis J., Saaf J., Wetterberg L. Calcium and magnesium concentrations in affective disorder: difference between plasma and serum in relation to symptoms. Acta Psychiatr Scand. 1989;80:527-537.
  • [24] Widmer J., Bovier P., Karege F. Evolution of blood magnesium, sodium and potassium in depressed patients followed for three months. Neuropsychobiology. 1992;26:173-179.
  • [25] Widmer J., Henrotte J.G., Raffin Y., Bovier P., Hilleret H., Gaillard J.M. Relationship between erythrocyte magnesium, plasma electrolytes and cortisol, and intensity of symptoms in major depressed patients. J Affect Disord. 1995;34:201-209.
  • [26] Camardese G., De R.L., Pizi G. Plasma magnesium levels and treatment outcome in depressed patients. Nutr Neurosci. 2012;15:78-84.
  • [27] Zieba A., Kata R., Dudek D., Schlegel-Zawadzka M., Nowak G. Serum trace elements in animal models and human depression: Part III. Magnesium. Relationship with copper. Hum Psychopharmacol. 2000;15:631-635.
  • [28] Barragan-Rodriguez L., Rodriguez-Moran M., Guerrero-Romero F. Depressive symptoms and hypomagnesemia in older diabetic subjects. Arch Med Res. 2007;38:752-756.
  • [29] Kamei K., Tabata O., Muneoka K., Muraoka S.I., Tomiyoshi R., Takigawa M. Electrolytes in erythrocytes of patients with depressive disorders. Psychiatry Clin Neurosci. 1998;52:529-533.
  • [30] Jung K.I., Ock S.M., Chung J.H., Song C.H. Associations of serum Ca and Mg levels with mental health in adult women without psychiatric disorders. Biol Trace Elem Res. 2010;133:153-161.
  • [31] Young L.T., Robb J.C., Levitt A.J., Cooke R.G., Joffe R.T. Serum Mg2+ and Ca2+/Mg2+ ratio in major depressive disorder. Neuropsychobiology. 1996;34:26-28.
  • [32] Murck H. Ketamine, magnesium and major depression – from pharmacology to pathophysiology and back. J Psychiatr Res. 2013;47:955-965.
  • [33] Poleszak E., Wlaz P., Kedzierska E. NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice. Pharmacol Biochem Behav. 2007;88:158-164.
  • [34] Poleszak E. Modulation of antidepressant-like activity of magnesium by serotonergic system. J Neural Transm. 2007;114:1129-1134.
  • [35] Cardoso C.C., Lobato K.R., Binfare R.W. Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:235-242.
  • [36] Pochwat B., Szewczyk B., Sowa-Kucma M. Antidepressant-like activity of magnesium in the chronic mild stress model in rats: alterations in the NMDA receptor subunits. Int J Neuropsychopharmacol. 2014;17:393-405.
  • [37] The neurobiological basis of suicide. Frontiers in neuroscience. In: Dwivedi Y., eds. Boca Raton (FL): CRC Press/Taylor & Francis; 2012.
  • [38] Gould T.D., Manji H.K. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology. 2005;30:1223-1237.
  • [39] King D.E., Mainous A.G. III, Geesey M.E., Ellis T. Magnesium intake and serum C-reactive protein levels in children. Magnes Res. 2007;20:32-36.
  • [40] Depoortere H., Francon D., Llopis J. Effects of a magnesium-deficient diet on sleep organization in rats. Neuropsychobiology. 1993;27:237-245.
  • [41] Decollogne S., Tomas A., Lecerf C., Adamowicz E., Seman M. NMDA receptor complex blockade by oral administration of magnesium: comparison with MK-801. Pharmacol Biochem Behav. 1997;58:261-268.
  • [42] Poleszak E., Wlaz P., Kedzierska E. Effects of acute and chronic treatment with magnesium in the forced swim test in rats. Pharmacol Rep. 2005;57:654-658.
  • [43] Fromm L., Heath D.L., Vink R., Nimmo A.J. Magnesium attenuates post-traumatic depression/anxiety following diffuse traumatic brain injury in rats. J Am Coll Nutr. 2004;23:529S-533S.
  • [44] Haj-Mirzaian A., Amiri S., Kordjazy N. Blockade of NMDA receptors reverses the depressant, but not anxiogenic effect of adolescence social isolation in mice. Eur J Pharmacol. 2015;750:160-166.
  • [45] Pochwat B., Sowa-Kucma M., Kotarska K., Misztak P., Nowak G., Szewczyk B. Antidepressant-like activity of magnesium in the olfactory bulbectomy model is associated with the AMPA/BDNF pathway. Psychopharmacology. 2015;232:355-367.
  • [46] Poleszak E., Szewczyk B., Wlaz A. D-serine, a selective glycine/N-methyl-D-aspartate receptor agonist, antagonizes the antidepressant-like effects of magnesium and zinc in mice. Pharmacol Rep. 2008;60:996-1000.
  • [47] Poleszak E., Wosko S., Serefko A., Szopa A., Wlaz A., Szewczyk B. Effects of ifenprodil on the antidepressant-like activity of NMDA ligands in the forced swim test in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2013;46:29-35.
  • [48] Serefko A., Szopa A., Wlaz A., Wosko S., Wlaz P., Poleszak E. Synergistic antidepressant-like effect of the joint administration of caffeine and NMDA receptor ligands in the forced swim test in mice. J Neural Transm. 2016;123:463-472.
  • [49] Socala K., Nieoczym D., Poleszak E., Wlaz P. Influence of the phosphodiesterase type 5 inhibitor, sildenafil, on antidepressant-like activity of magnesium in the forced swim test in mice. Pharmacol Rep. 2012;64:205-211.
  • [50] Nikseresht S., Etebary S., Karimian M., Nabavizadeh F., Zarrindast M.R., Sadeghipour H.R. Acute administration of Zn, Mg, and thiamine improves postpartum depression conditions in mice. Arch Iran Med. 2012;15:306-311.
  • [51] Weston P.G. Magnesium as a sedative. Am J Psychiatry. 1921;78:637-638.
  • [52] Chouinard G., Beauclair L., Geiser R., Etienne P. A pilot study of magnesium aspartate hydrochloride (Magnesiocard) as a mood stabilizer for rapid cycling bipolar affective disorder patients. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14:171-180.
  • [53] Facchinetti F., Borella P., Sances G., Fioroni L., Nappi R.E., Genazzani A.R. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991;78:177-181.
  • [54] Walker A.F., De Souza M.C., Vickers M.F., Abeyasekera S., Collins M.L., Trinca L.A. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health. 1998;7:1157-1165.
  • [55] Cox I.M., Campbell M.J., Dowson D. Red blood cell magnesium and chronic fatigue syndrome. Lancet. 1991;337:757-760.
  • [56] Kalinin V.V., Zheleznova E.V, Rogacheva T.A. [A use of Magne-B6 in the treatment of anxiety-depressive states in patients with epilepsy]. [Article in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 2004;104:51-55.
  • [57] Enya M., Kanoh Y., Mune T. Depressive state and paresthesia dramatically improved by intravenous MgSO4 in Gitelman's syndrome. Intern Med. 2004;43:410-414.
  • [58] Eby G.A., Eby K.L. Rapid recovery from major depression using magnesium treatment. Med Hypotheses. 2006;67:362-370.
  • [59] Barragan-Rodriguez L., Rodriguez-Moran M., Guerrero-Romero F. Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnes Res. 2008;21:218-223.
  • [60] Najam R., Bano N., Ahmed S.P. The therapeutic role of magnesium in different depressive syndromes of female patients. Pak J Pharmacol. 2010;27:1-8.
  • [61] de Souza M.C., Walker A.F., Robinson P.A., Bolland K. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. J Womens Health Gend Based Med. 2000;9:131-139.
  • [62] Ranade V.V., Somberg J.C. Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. Am J Ther. 2001;8:345-357.
  • [63] Walker A.F., Marakis G., Christie S., Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res. 2003;16:183-191.
  • [64] PDR for nutritional supplements. In: Hendler S.S., Rorvik D.R., eds. Montvale: Medical Economics Company, Inc; 2001.